SUBLOCADE (Indivior Pty Ltd)
Product name
SUBLOCADE
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
194 (255 working days)
Active ingredients
buprenorphine
Registration type
EOI
Indication
SUBLOCADE is indicated for treatment of opioid dependence, within a framework of medical, social and psychological treatment.